Two different mechanisms leading to increased current have been described for the small-molecule human ether-à -go-gorelated gene (herg) activator NS1643 [1,3-bis-(2-hydroxy-5-trifluoromethylphenyl)-urea]. On herg1a channels expressed in Xenopus laevis oocytes, it mainly acts via attenuation of inactivation and for rat (r) erg1b channels expressed in human embryonic kidney (HEK)-293 cells, it strongly shifts the activation curve to the left. We now investigated the NS1643 effects on erg1b channels in more detail and performed comparative experiments with rat and human erg1a in different expression systems. Significant differences were observed between expression systems, but not between the rat and human isoform. In HEK-293 or Chinese hamster ovary (CHO) cells, activation of rat erg1b channels occurred in a dose-dependent manner with a maximum current increase of 300% obtained with 10 M NS1643. In contrast, the NS1643-induced strong leftward shift in the voltage dependence of activation further increased with higher drug concentration, needed more time to develop, and exhibited use dependence. Coexpression of KCNE1 or KCNE2 did not attenuate this NS1643 effect on erg1 channel activation and did thus not mimic the lower drug potency on this parameter observed in oocytes. NS1643 (10 M) slowed erg1b channel deactivation and recovery from inactivation without significant changes in activation and inactivation kinetics. With the exception of accelerated activation, NS1643 affected erg1a channels similarly, but the effect was less pronounced than in erg1b or erg1a/1b channels. It is noteworthy that rerg1b and herg1a inactivation estimated from fully activated current voltage relationships were unaltered in the continued presence of 10 M NS1643 in the mammalian expression systems, indicating qualitative differences from NS1643 effects in X. laevis oocytes.
Introduction
The cardiac action potential controls the contraction of the heart by a very accurate regulated process that is mediated by changes in membrane permeability to specific ions. Voltage-gated potassium channels are of crucial importance for the action potential duration and the refractory period. In particular, the slow (I Ks ) and the rapid (I Kr ) delayed rectifier play an important role in the repolarization of cardiac muscle cells (Sanguinetti and Jurkiewicz, 1990) . The pore-forming component of the I Kr channel is encoded by the human ether-à -go-go-related gene (herg) (Warmke and Ganetzky, 1994; Sanguinetti et al., 1995; Trudeau et al., 1995) . The typical gating of erg channels, including voltage-dependent fast inactivation and recovery from inactivation as well as slow deactivation, supports the plateau phase and explains the high impact during the repolarization of the cardiac action potential.
In addition to the classic full-length herg (herg1a) channel, the N-terminal splice variant herg1b was identified in the heart (Lees-Miller et al., 1997; London et al., 1997) and was shown to contribute to native heteromeric erg1a/1b channels in the heart (Jones et al., 2004) . erg1b lacks a wide part of the N terminus of herg1a (amino acids 1-376), including the PAS [periodicity/aryl hydrocarbon receptor nuclear translocator/single-minded (Per-ARNT-Sim)] or EAG domain, and exhibits instead a much shorter unique N-terminal sequence of 36 amino acids. Because the EAG domain is crucial for the slow deactivation of erg channels (Schö nherr and Heinemann, 1996) , erg1b shows much faster deactivation kinetics than erg1a (Lees-Miller et al., 1997; London et al., 1997) . The extent and significance of contributions of ␤-subunits such as KCNE1 or KCNE2 to the native I Kr conducting channels are still a matter of investigation (Weerapura et al., 2002) .
In addition to their cardiac expression, erg1a and erg1b subunits are coexpressed in many excitable tissues, including a number of different smooth muscle preparations as well as several regions of the central nervous system, where erg2 or erg3 channel subunits also might be coexpressed. In these tissues, erg channels often modulate excitability by contributing to the maintenance of the resting membrane potential (for review, see Schwarz and Bauer, 2004) .
In the human heart, decreased function of I Kr either by genetic mutations or more commonly by pharmacological block of erg channels can induce a long QT syndrome type 2. Reduced repolarizing currents result in a prolongation of the ventricular action potential, which increases the risk for life-threatening torsades de pointes arrhythmia and ventricular fibrillation. Therefore, unintended druginduced block of erg channels presents a significant clinical and economical challenge in pharmacotherapy (Fermini and Fossa, 2003) .
The induction of increased opening of erg channels and thus the acceleration of cardiac repolarization and shortening of action potential duration could present a novel antiarrhythmic principle . Consequently, an effort was made to develop compounds with herg channelactivating properties. In the last few years, several herg activators acting with different mechanisms have been identified (for review, see Li and Dong, 2010) . The compound 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) activates erg1 channels heterologously expressed in Xenopus laevis oocytes (Casis et al., 2006; Hansen et al., 2006; Xu et al., 2008) as well as the native I Kr (Hansen et al., 2006; Diness et al., 2008) . In animal studies, NS1643 has already been shown to provide antiarrhythmic properties (Diness et al., 2008; Killeen et al., 2008) , but proarrhythmic effects have also been observed (Diness et al., 2008; Lu et al., 2008) .
Reduced inactivation was described as the main mechanism of herg1a channel activation by NS1643 (Casis et al., 2006; Hansen et al., 2006; Xu et al., 2008) . As we reported earlier, NS1643 exhibited a much stronger effect and a different mechanism of activation on rat erg1b (rerg1b) channels expressed in human embryonic kidney (HEK)-293 cells, where a strong shift in the voltage dependence of activation to more negative potentials was observed (Mewe et al., 2008) . We have now extended our analysis and performed further experiments to investigate the pronounced activation of rerg1b channels by NS1643 in a mammalian expression system in more detail. In addition, we investigated whether reported discrepancies resulted from the use of different splice variants, different species or different expression systems. We found that the strongest effects of NS1643 on erg1b channels concerned the voltage dependence of activation and the deactivation kinetics, and our results show that the activation by NS1643 is indeed somewhat more pronounced for erg1b than for erg1a channels. Our data also suggest that the mechanism of erg1 channel activation by NS1643 depends on the expression system, because erg1a and erg1b inactivation remained unaltered in mammalian cells, which is in sharp contrast to the main mechanism of herg channel activation by NS1643 in X. laevis oocytes.
Materials and Methods

Cell Culture
HEK-293 cells, Chinese hamster ovary (CHO) cells, and CHO cells stably transfected with herg1a were cultured in Dulbecco's modified Eagle's medium (Invitrogen GmbH, Karlsruhe, Germany) supplemented with 1% penicillin-streptomycin-glutamine (Invitrogen) and 10% fetal calf serum (Biother, Kelkheim, Germany) at 37°C in a humidified incubator (95% air, 5% CO 2 ). The culture medium was changed every 2 to 3 days, and the cells were passaged when they reached confluence.
X. laevis Oocytes
X. laevis oocytes were collected under anesthesia (1.2 g/l tricaine), and the follicular tissue was removed by collagenase A (Roche, Basel, Switzerland). Before and after injection of cRNA, oocytes were kept at 18°C in Barth medium consisting of 88 mM NaCl, 3 mM KCl, 2.4 mM NaHCO 3 , 0.82 mM MgSO 4 , 0.3 mM Ca(NO 3 ) 2 , 0.41 mM CaCl 2 , and 15 mM Tris; pH adjusted to 7.4 with NaOH, supplemented with 50 mg/l gentamicin.
Heterologous Expression
Microinjection. HEK-293 cells were plated on glass coverslips coated with poly-D-lysine (Sigma-Aldrich, Deisenhofen, Germany) in 35-mm plastic culture dishes (NUNC, Wiesbaden, Germany) and microinjected with a Transjector 5246 (Eppendorf, Hamburg, Germany) with cDNA encoding either rat erg1b [rerg1b; 30 ng/l (Hirdes et al., 2005) ] or rat erg1a [rerg1a; 10 ng/l (Bauer et al., 1998) ] cloned into the pcDNA3 vector (Invitrogen). To allow detection of successfully expressing HEK-293 cells, EGFP-N1 (10 ng/l; Clontech, Heidelberg, Germany) was coexpressed. Electrophysiological experiments were performed 8 to 24 h after injection. X. laevis oocytes were injected with cRNA encoding either rerg1a or herg1a using a Nanoliter 2000 microinjector (World Precision Instruments, Berlin, Germany). Oocytes were used for experiments 3 to 4 days after injection.
Transfection. HEK-293 or CHO cells plated onto poly-D-lysinecoated coverslips in 35-mm culture dishes were transfected with the relevant cDNA using LipofectAMINE 2000 reagent (Invitrogen, Karlsruhe, Germany) according to the manufacturer's instructions. For separate expression of rerg1a and rerg1b channels, cDNA encoding rerg1a (1 ng/l) or rerg1b (1.8 ng/l) was applied together with cDNA encoding EGFP-N1 (0.8 ng/l; Clontech). Only for coexpression experiments of rerg1a together with rerg1b, rerg1a with C-terminally tagged EGFP [1 ng/l (Kirchberger et al., 2006) ] and rerg1b with C-terminally tagged DsRed [1 ng/l (Kirchberger et al., 2006) ] were used to enable identification of cells expressing both rerg1 subunits. In another set of experiments, rat KCNE1 (5.4 up to 10.8 ng/l; GenBank Accession no. NM_012973) or KCNE2 (5.4 ng/l up to 18 ng/l; GenBank Accession no AF071003) was coexpressed together with rat erg1a or erg1b. Experiments were performed 8 to 48 h after transfection.
Electrophysiology. Membrane currents of erg1 channel expressing HEK-293 or CHO cells were recorded in the conventional wholecell configuration of the patch-clamp technique. If NS1643 was applied during an experiment, cells were continuously superfused with external solution throughout the experiment. Patch pipettes were made from 1.5-mm diameter borosilicate glass capillaries with resistances of 2 to 4 M⍀. Data were low-pass filtered at 3 kHz and compensated for both fast and slow capacity transients before the pulse protocols. The access resistance ranged from 3 to 12 M⍀, and series resistance compensation was as high as possible (60-85%). Data were not corrected for the liquid junction potential error (ϳ4 mV). An EPC-9 patch clamp amplifier was used in combination with the PULSE stimulation and data acquisition software (HEKA, Lambrecht, Germany). X. laevis oocyte currents were recorded by twoelectrode voltage-clamp technique using a Turbo TEC 03 amplifier (npi electronic GmbH, Tamm, Germany) and PULSE acquisition software. All electrophysiological experiments were performed at room temperature.
Solutions and Chemicals
HEK-293 and CHO Cells. The external Ringer solution contained 140 mM NaCl, 5 mM KCl, 0.8 mM MgCl 2 , 1 mM CaCl 2 , 10 mM HEPES, and 5 mM glucose; pH adjusted to 7.35 with NaOH. The standard pipette solution contained 140 mM KCl, 2 mM MgCl 2 , 1 mM CaCl 2 , 10 mM HEPES, and 2.5 mM EGTA [66 nM free Ca 2ϩ as calculated with EQCAL software (Biosoft, Cambridge, UK)] pH adjusted to 7.35 with KOH.
X. laevis Oocytes. Experiments were performed in external solution containing 91 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 5 mM HEPES; pH adjusted to 7.4 with NaOH. Pipettes were filled with 3 M KCl solution.
N ethyl]-4-piperidinyl]carbonyl]phenyl]methanesulfonamide dihydrochloride (E-4031) was a generous gift from Eisai (Tokyo, Japan) and NS1643 was from NeuroSearch A/S (Ballerup, Denmark) or purchased from Tocris/Biozol (Eching, Germany). Stock solutions of E-4031 (10 mM in distilled water) and NS1643 (10 or 30 mM in dimethyl sulfoxide) were dissolved in external solution to yield the final concentrations.
Unless otherwise mentioned, HEK-293 cells were used as a heterologous mammalian expression system to examine the effects of the erg activator NS1643 on rerg1b channels. In one type of experiments, control measurements and measurements in the presence of NS1643 were performed on the same cells. In another type of experiments, control measurements and measurements in the prolonged presence (15-60 min) of NS1643 were performed on different cells. To analyze dose-dependent effects of NS1643 on the voltage dependence of activation and the amplitude of rerg1b currents, concentrations between 0.1 and 30 M NS1643 were tested. Further experiments on rerg1b, rerg1a, and rerg1a/1b channels were performed with 10 M NS1643. 30 M NS1643 was used in experiments on herg1a and rerg1a channels expressed in X. laevis oocytes.
Data Analysis
Experimental data are given as means Ϯ S.E.M., with n representing the number of experiments from different cells. Depending on the type of experiment, Student's two-tailed paired or unpaired t test was used to assess statistical significance indicated by p Ͻ 0.05, p Ͻ 0.01, and p Ͻ 0.001. Processing of the electrophysiological data were performed with PulseFit 8.65 (HEKA), Excel (Microsoft Corp., Redmond, WA) and SigmaPlot 11.0 (Systat Software, Inc., San Jose, CA).
To assess the voltage dependence of erg channel activation, normalized data were fitted with a Boltzmann equation: y ϭ 1/(1 ϩ exp (Ϫ(V ϪV 0.5 )/k)), where V 0.5 is the potential of half-maximal erg current amplitude and k is the slope factor. The summarized data on the dose dependence of NS1643 effects given in Table 1 also include data from experiments presented in Mewe et al. (2008) . The time course of activation was determined by an envelope-of-tail protocol. Tail current amplitudes were normalized to the maximal amplitude of the control experiments, and, apart from the first data points, data were fitted with a single exponential function yielding the time constant of activation ( act ) and-for rerg1b analysis-a delay (d):
, where t is the time and I is the current amplitude. The time constant of inactivation was obtained by fitting a single exponential function to decaying erg current traces: I(t) ϭ I min ϩ (I max Ϫ I min ) ϫ exp (Ϫt/ inact ), where t is the time and I is the current amplitude. For erg1b channels, time constants of recovery from inactivation ( recovery ) and deactivation ( deact ) were obtained by fitting current traces with the sum of two exponential functions describing recovery from inactivation as well as subsequent deactivation. For erg1a and erg1a/1b channels, fit procedures with three exponential functions were used, yielding the time constant of recovery from inactivation ( recovery ) and the time constants for fast ( deact,fast ) and slow deactivation ( deact,slow ).
Results
Dose-Dependent Effects of NS1643 on rerg1b Channels. rerg1b currents were recorded in the same cells before (control) and after application of 0.1, 1, 10, or 30 M NS1643. Representative rerg1b membrane currents elicited in a HEK-293 cell under control conditions, after application of 10 M NS1643 and additional application of 10 M E-4031, are displayed in Fig. 1A . Under control conditions, outward currents were evoked at depolarizing test pulse potentials more positive than approximately Ϫ40 mV. The amplitude of these rerg1b currents increased up to potentials of approximately ϩ10 mV. Potentials that were more positive yielded lower amplitudes, resulting in a bell-shaped current-voltage curve (Fig. 1B) , reflecting the inward rectification of erg channels resulting from slow activation and fast inactivation. As summarized in Table 1 , the highest increase in erg1b current amplitude was observed after application of 10 M NS1643, whereas higher NS1643 concentrations led to a less intense increase. Under control conditions, the steady-state amplitude was maximal at approximately ϩ10 mV, and NS1643 induced a concentration-dependent shift in this maximum to more negative potentials (1 M, ϩ10 mV; 10 M, Ϫ10 mV; 30 M, Ϫ20 mV; Fig. 1B) .
The typical hook-like shape of erg tail currents is evoked by rapid recovery from inactivation followed by relatively slower deactivation. Because the peak tail-current amplitude mirrors the amount of channels activated by the preceding test pulse, the voltage dependence of rerg1b channel activation was assessed by plotting the peak tail-current amplitudes against the prepulse potential. A Boltzmann function-comprising the isochronal activation curve of the rerg1b current-was fitted to the data points to determine the potential of half-maximal rerg1b channel activation (V 0.5 ) and the slope factor (k). As described previously (Mewe et al., 2008) , the NS1643-induced erg1b current increase was accompanied by a strong shift in the voltage dependence of activation. The shift in half-maximal activation (⌬V 0.5 ) was concentration-dependent and ranged from ⌬V 0.5 ϭ Ϫ6.3 Ϯ 3.0 mV (n ϭ 5; p ϭ 0.105) at 0.1 M NS1643 to ⌬V 0.5 ϭ Ϫ62.0 Ϯ 10.0 mV (n ϭ 4; p ϭ 0.023) at 30 M NS1643 (see Table 1 ). The control measurements yielded a V 0.5 value of Ϫ1.7 Ϯ 1.3 mV (n ϭ 25). The slope factor k did not change significantly at any of the tested NS1643 concentrations. In control experiments performed in the absence of drug, the voltage dependence of 
(n ϭ 4)* (n ϭ 6)* 10 M Ϫ33.4 Ϯ 4.5 mV 304 Ϯ 77% 283 Ϯ 90% (n ϭ 10)*** (n ϭ 7)** (n ϭ 10)* 30 M Ϫ62.0 Ϯ 10.0 mV 121 Ϯ 61% 185 Ϯ 20% (n ϭ 4)* (n ϭ 4)* (n ϭ 4)* ⌬V 0.5 , shift in the potential for half-maximal current activation; n, number of experiments on different cells.
* P Ͻ 0.05. ** P Ͻ 0.01. *** P Ͻ 0.001.
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Because the leftward shift in the voltage dependence of activation steadily increased with higher concentrations of NS1643, the presence of an optimum of the NS1643 effect on erg1b current amplitude points to an additional channel blocking effect of NS1643 at higher concentrations as described previously for erg1a channels (Casis et al., 2006) .
Time and Use Dependence of NS1643 Effects. To investigate and compare the time course of the two different agonistic effects of NS1643 on rerg1b channels, a special test pulse sequence was applied to obtain information for both, the shift in the voltage dependence of activation and the increase in amplitude (Fig. 2) . During the first Ϫ40-mV test pulse, no significant rerg1b channel activation was obtained under control conditions. After application of 10 M NS1643, increasing channel activation was detectable as a result of the slowly developing leftward shift in the voltage dependence of activation. The ratio of the maximal current amplitudes elicited with the first and the second potential step to Ϫ40 mV was used to determine the fraction of channels already activating at Ϫ40 mV. After application of NS1643, this fraction increased from approximately zero (no activation at Ϫ40 mV) to almost 1 (all channels already activated at Ϫ40 mV), serving as a nonlinear measure of the shift in the voltage dependence of activation. The tail-current amplitude normalized to its maximal value during the experiment was evaluated as second parameter. The time course of changes in erg1b current amplitude and of shifts in the voltage dependence of activation induced by application of 10 M NS1643 was traced by repeating the test pulse sequence every 7 s. A representative family of current traces is displayed in Fig. 2A . Even though the time courses of the two different effects varied considerably between individual experiments, the shift in the voltage dependence of activation always required more time to reach a maximum than the increase in erg1b current amplitude (n ϭ 5). In longer experiments, the current amplitude showed a tendency to decrease despite the continued presence of NS1643. In contrast, the shift in the voltage dependence of activation never reversed.
Use dependence of the NS1643 effects was tested in experiments including a 5-min interruption of the repeated test pulses at the time of application of 10 M NS1643. After this 5-min interval at a holding potential of Ϫ80 mV, the test pulse sequence was applied again every 7 s (see Fig. 2B ). With the first pulse sequence after the break, the increase in rerg1b tail-current amplitude was almost maximal, whereas the shift in the voltage dependence of activation had just partly developed and showed a strong increase with the next pulse sequences. A comparison of experiments with and without continuous pulsing suggests that the time course of the increase in amplitude might have been similar in both types of experiments, whereas the time course of the shift in the voltage dependence of activation differed considerably. With continuous pulsing, 50% of rerg1b channels could be activated at Ϫ40 mV after approximately 2.5 min (145.6 Ϯ 21.6 s; n ϭ 5); when NS1643 was applied at a constant negative potential of Ϫ80 mV, less than 50% (39 Ϯ 8%; n ϭ 6) of the rerg1b channels were activated at Ϫ40 mV during the first test pulse sequence 5 min after NS1643 application. This difference indicates a use dependence of the shift in the voltage dependence of activation by NS1643.
Effect of NS1643 on the Time Course of Activation of rerg1b Currents. The effect of NS1643 on rerg1b activation kinetics was investigated by an envelope of tail protocol. Depending on the duration of the depolarizing pulse, an increasing fraction of rerg1b channels activated, mirrored by the peak tail-current amplitude elicited by the hyperpolarizing pulse. Representative rerg1b current traces as well as averaged data before and after application of 10 M NS1643 are shown in Fig. 3 . The peak tail-current amplitudes before and after application of 10 M NS1643 were normalized to the maximum control current and plotted against the duration of the preceding pulse. To identify the time constant of activation ( activation ), a single exponential function including a delay (d) was fitted to the data points. The delay was introduced to respect initial closed-closed transitions of the Fig. 1 . NS1643 strongly activates rerg1b channels. Membrane currents were recorded in HEK-293 cells expressing rerg1b channels. Rat erg1b channel activation was assessed by 4-s depolarizing test pulses between Ϫ100 mV and ϩ60 mV with 10-mV increments, followed by a constant pulse to Ϫ40 mV for 5 s (see pulse diagram). A, representative rerg1b current traces. Currents were measured in the same cell before (control) and after application of 10 M NS1643 and 10 M E-4031. B, current-voltage relationship of outward current amplitudes measured at the end of the depolarizing pulses under control conditions (n ϭ 15) and after application of 1 M (n ϭ 4), 10 M (n ϭ 7) and 30 M NS1643 (n ϭ 4). For each experiment, current amplitudes were normalized to the maximum of the respective control. Data are means Ϯ S.E.M.
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Effect of NS1643 on The Time Course of Recovery from Inactivation and Deactivation. The effect of 10 M NS1643 on the time course of recovery from inactivation and deactivation was analyzed by an availability protocol (Fig. 4) . Starting from the fully activated and predominantly inactivated state of the erg channels, the variable test pulses Fig. 2 . Time course and use dependence of NS1643 effects. Rat erg1b currents were elicited in HEK-293 cells before and various time after the start of NS1643 application from a holding potential of Ϫ80 mV by the potential sequence shown in the pulse protocol. Each pulse sequence consisted of a 2-s pulse to Ϫ40 mV, followed by a step to 0 mV, a 0.5-s test pulse to 40 mV to achieve maximal channel activation, and a final second potential step to Ϫ40 mV to elicit maximal tail-current amplitudes. Some experiments were performed with slightly different pulse durations (see pulse protocol). After control runs of the test pulse sequence, application of 10 M NS1643 was started and the pulse sequence was either repeated every 7 s or it started after a gap of 5 min at the holding potential of Ϫ80 mV. A and B, superimposed current traces and evaluation of an experiment with continuous pulsing (A) and of an experiment with interrupted pulsing (B). Control current traces are displayed in black. Gray traces have been recorded after the start of NS1643 application. Ab and Bb display the time courses of the increment in the tail-current amplitude as well as of the fraction of erg1b channels activated at the end of the first pulse to Ϫ40 mV, indicating a shift in the voltage dependence of activation. The tail-current amplitudes were measured at the second Ϫ40-mV test pulse (marked with a circle) and normalized to the maximum tail-current amplitude recorded in the presence of NS1643. The fraction of erg1b channels activated at Ϫ40 mV was defined as the quotient of the rerg current amplitude at the end of the first Ϫ40-mV test pulse (marked with an asterisk) and the peak tail-current amplitude at the second Ϫ40-mV test pulse of the same pulse sequence. This current ratio served as a nonlinear measure of the shift in the voltage dependence of erg1b channel activation. Fig. 3 . Effect of NS1643 on the time course of activation of rerg1b channels. Membrane currents of HEK-293 cells expressing rerg1b channels were evoked by depolarizing pulses to ϩ40 mV of increasing duration (between 10 and 5130 ms), followed by a 200-ms hyperpolarization to Ϫ100 mV. The holding potential was Ϫ110 mV (see pulse protocol). A, representative membrane currents of one cell before (Control) and after application of 10 M NS1643. B, peak tail-current amplitudes were normalized to the maximum of the respective control, averaged and plotted against the duration of the preceding depolarizing pulse (n ϭ 6). Mean data points were fitted with single exponential functions including a delay (Control, activation ϭ 136.9 ms, delay ϭ 14.4 ms; NS1643, activation ϭ 88.5 ms, delay ϭ 7.7 ms). Data are means Ϯ S.E.M. Figure 4A shows rerg1b current traces obtained before and different time after the start of 10 M NS1643 application. NS1643 induced a marked slowing of the time course of recovery from inactivation and deactivation, but the time course of these kinetic effects was delayed compared with the NS1643 effects on current amplitude and seemed to parallel the changes in the voltage dependence of activation. Under control conditions, recovery ranged between 0.64 Ϯ 0.08 ms at Ϫ120 mV and 8.97 Ϯ 0.61 ms at 0 mV and increased by application of NS1643 to 2.43 Ϯ 0.35 ms at Ϫ120 mV (n ϭ 6; p ϭ 0.004) and to 21.93 Ϯ 1.93 ms at 0 mV (n ϭ 6; p ϭ 0.001; Fig. 4B ). The slowing of deactivation kinetics, analyzed at pulse potentials between Ϫ120 and Ϫ90 mV, was even stronger: at Ϫ120 mV, deact increased from 10.0 Ϯ 1.1 (control) to 54.6 Ϯ 7.9 ms (10 M NS1643; n ϭ 9; p Ͻ 0.0001), and at Ϫ90 mV, deact changed from 19.2 Ϯ 2.7 to 154.7 Ϯ 24.7 ms (n ϭ 9; p Ͻ 0.0001; Fig. 4C) .
Effect of NS1643 on The Inactivation of rerg1b Channels. The time course of inactivation of rerg1b channels was investigated by a triple-pulse protocol. Starting from a holding potential of Ϫ80 mV, a 500-ms depolarizing pulse to ϩ80 mV (P1) was used to fully activate and inactivate rerg1b channels. A 10-ms variable test pulse (P2) was then applied, leading to voltage-dependent recovery from inactivation, mirrored by the current amplitude elicited by a subsequent 150-ms depolarizing pulse to ϩ60 mV (P3). erg current amplitudes elicited by P3 massively increased in the presence of NS1643, hampering proper voltage control. To reduce the influence of incomplete voltage control, we analyzed current traces with similar amplitude before and after NS1643 application. Monoexponential fits to the decay phase of P3 current traces yielded similar mean values of inact of 4.7 Ϯ 0.3 ms at ϩ60 mV under control conditions and of 4.8 Ϯ 0.4 ms (n ϭ 7; p ϭ 0.976) after application of 10 M NS1643. The same type of pulse protocol was previously used to identify NS1643-induced shifts in the voltage dependence of inactivation of erg1a channels (Hansen et al., 2006) . A similar evaluation was not appropriate for rerg1b because of the drastic increase in current amplitude and strong slowing of the recovery from inactivation (Fig. 4B) , rendering a comparability of the data obtained before and after NS1643 application impossible.
Another attempt was made to assess the effect of NS1643 on rerg1b channel inactivation using the fully activated current-voltage relationship. Experiments were carried out either without or with prolonged presence of NS1643 in the bath to assess the "steady-state" effects of the drug on the inactivation of rerg1b channels. Problems associated with the pronounced NS1643-induced increase in erg1b current amplitudes were minimized by choosing the experiments for analysis to roughly match the current amplitudes in the two experimental groups (Fig. 5A, a and b) . To account for a possible use dependence of the NS1643 effect, several pulse protocols preceded the one used for analysis in both groups. Figure 5B shows that the normalized fully activated currentvoltage plots for the control and the NS1643 group were similar but not identical. Upon repolarizing potential steps between ϩ80 and 0 mV, the voltage-dependent increase in erg1b current amplitude due to increased recovery from inactivation was almost identical. A deviation of the data occurred in the potential range where voltage-dependent deactivation affected the amplitudes of the control currents clearly more than the currents measured in the presence of NS1643, which is explained by the pronounced leftward shift in the activation curve. Mean peak current values of both groups served to calculate the relative erg1b conductance (Fig. 5C) . Data in the potential range with no apparent or marginal deactivation were considered for fits with a Boltzmann function. It is noteworthy that the resulting V 0.5 values of Ϫ15.4 mV (control) and Ϫ13.4 mV (NS1643) are quite close to the reported potential for half-maximal steady-state inactivation of rerg1b channels obtained with a classic triple- Fig. 4 . Recovery from inactivation and deactivation kinetics of rerg1b channels are strongly slowed by NS1643. Membrane currents of HEK-293 cells heterologously expressing rerg1b channels were elicited by 0.5-s depolarizations to ϩ80 mV followed by variable 1-s test pulses from ϩ80 to Ϫ120 mV with 10-mV decrements (see pulse protocol). A, membrane currents from the same cell before (Control) as well as 2 and 7 min after the start of 10 M NS1643 application. B, averaged time constants of recovery from inactivation ( recovery ) as a function of the pulse potential before and after application of 10 M NS1643 (n ϭ 6). NS1643 evoked a significant increase of recovery ‫,ءء(‬ p Ͻ 0.01 for all displayed potentials, except for Ϫ60 mV, where p Ͻ 0.05). Data points for potentials close to the potassium equilibrium potential were omitted. C, time constants of deactivation ( deact ) as a function of the test pulse potential (n ϭ 9). NS1643 (10 M) evoked a highly significant increase of deact ‫,ءءء(‬ p Ͻ 0.001 for all displayed potentials). Data points are means Ϯ S.E.M. Effects of NS1643 on rerg1a and rerg1a/1b Channels. Because we found much stronger effects and a different mechanism of activation of rerg1b channels expressed in mammalian cells compared with the results on herg1a channels in X. laevis oocytes, we also investigated the effects of NS1643 on the voltage dependence of activation of rerg1a channels expressed in HEK-293 cells. Representative rerg1a current traces as well as averaged data before and after application of 10 M NS1643 are shown in Fig. 6A . A clear shift in the voltage dependence of rerg1a activation was observed: V 0.5 changed from Ϫ18.9 Ϯ 3.9 mV under control conditions to Ϫ45.7 Ϯ 4.4 mV (n ϭ 6; p ϭ 0.001) after application of 10 M NS1643. The slope factor k did not alter significantly. The increase in the peak tail-current amplitude by 39 Ϯ 16% (n ϭ 6; p ϭ 0.156) was not significant, but the maximum outward current amplitude was clearly augmented by 136 Ϯ 18% (n ϭ 6; p ϭ 0.001).
Activation of erg1 Channels by NS1643 in HEK and
erg1a and erg1b subunits are coexpressed in many tissues and are able to form heteromeric channels (Jones et al., 2004; Guasti et al., 2005) . Therefore, we also tested NS1643 on heteromeric erg1a/1b channels. Figure 6B illustrates the prominent activation of rerg1a/1b channels by 10 M NS1643. V 0.5 shifted highly significant from Ϫ17.0 Ϯ 2.7 mV under control conditions to Ϫ55.4 Ϯ 2.1 mV (n ϭ 5; p Ͻ 0.0001) after NS1643 application. The peak tail-current amplitudes and the maximum outward current amplitudes increased significantly by 89 Ϯ 23% (n ϭ 5; p ϭ 0.023) and by 212 Ϯ 34% (n ϭ 5; p ϭ 0.003), respectively.
Inspection of the rerg1a and rerg1a/1b tail currents suggested that NS1643 slowed the time course of deactivation of both types of erg1 channels (Fig. 6 , Aa and Ba). Fits of the tail-current traces with the sum of three exponential equations allowed a more detailed analysis of the NS1643 effects, which are summarized in Table 2 . NS1643 increased the time constant of recovery from inactivation for rerg1a and for rerg1a/1b. The slowing of rerg1a/1b channel deactivation included increases of the time constants for fast and slow deactivation as well as an increase in the relative contribution of the slowly deactivating current component. The observed slowing of rerg1a tail currents resulted from decelerated fast deactivation combined with an increase in the relative contribution of the slowly deactivating current component, although the time constant for the latter process decreased.
To ensure that the observed strong effects of NS1643 on rerg1b and rerg1a channels are not specific to HEK-293 cells, additional experiments concerning the voltage dependence of activation and the amplitude of steady-state outward and tail currents were performed in CHO cells, heterologously expressing rerg1b or rerg1a channels. In these experiments, 10 M NS1643 also exerted strong activating effects, which did not differ from those observed in HEK cells (data not shown). The robust activating influence of NS1643 on rat erg1 channels is therefore reproducible in another mammalian expression system and is not specific to HEK-293 cells.
NS1643 Effects on herg1a Channels Expressed in CHO Cells. A single amino acid difference can be crucial for the effects of erg channel activators (Perry and Sanguinetti, 2008) . To check whether the small sequence differences between herg1a and rerg1a channels might underlie the different sensitivity to NS1643 of rerg1 channels investigated in mammalian expression systems compared with herg1 channels expressed in X. laevis oocytes, we performed additional measurements on herg1a channels using stably transfected CHO cells. After confirming that short-term application of 10 M NS1643 resulted in a considerable herg1a current increase, experiments were carried out either in the absence or with prolonged presence of NS1643 in the bath to assess the "steady-state" effects of the drug on the activation and inactivation of herg1a channels. As for rerg1b channels (data of Fig. 5 ), only part of the experiments were chosen for analysis to match the herg1a current amplitudes in the two experi- Fig. 5 . Effect of NS1643 on the fully activated current-voltage relationship of rerg1b channels. Membrane currents of HEK-293 cells heterologously expressing rerg1b channels were recorded either under control conditions or with 10 M NS1643 in the bath for at least 15 min. Experiments from different cells recorded without (Aa) or with (Ab) NS1643 were matched for similar rerg current amplitudes. The pulse protocol consisted of 0.5-s depolarizations to ϩ80 mV to fully activate the channels, followed by variable 1-s test pulses from ϩ80 to Ϫ120 mV with 10-mV decrement. B, peak current amplitudes (means Ϯ S.E.M.; n ϭ 5 for both control and NS1643) plotted against the test pulse potential. Before averaging, data were normalized to the maximum tail-current amplitude elicited with the test pulse to Ϫ120 mV. C, normalized conductance values were calculated from the mean current values given in B, using a reversal potential of Ϫ77.5 mV for control and for NS1643. Data points shown in gray were not considered for the Boltzmann fits (control, V 0.5 ϭ Ϫ15.4 mV, k ϭ Ϫ26.1 mV; NS1643, V 0.5 ϭ Ϫ13.4 mV; k ϭ Ϫ24.5 mV). (Figs. 7 and 8) . With prolonged exposure to 10 M NS1643, the voltage dependence of herg1a channel activation was shifted by almost 30 mV to more negative potentials (Fig. 7, A and B) . The differences in the potential for half-maximal activation between the two groups were highly significant (control, V 0.5 ϭ Ϫ28.3 Ϯ 1.3, n ϭ 9; NS1643, V 0.5 ϭ Ϫ55.3 Ϯ 2.1, n ϭ 8; p Ͻ 0.0001).
In contrast to the results on erg1b channels, these changes in the voltage dependence of activation were associated with a pronounced acceleration of herg1a current activation (Fig. 7, C and D) . Time constants of activation were determined for three different potentials with an envelope of tail protocol as described for erg1b. In the presence of 10 M NS1643, the values of activation amounted only to approximately half of the control values (Fig. 7D) .
As a measure of steady-state inactivation, the relative herg1a conductance was calculated from the fully activated current-voltage relationship (Fig. 8) . The normalized peak amplitudes of the herg1a currents were almost identical for the control group and the cells recorded with NS1643 in the bath (Fig. 8B) . Accordingly, the conductance curves were strikingly similar (Fig. 8C) , suggesting that the voltage dependence of herg1a inactivation was not altered by prolonged exposure to 10 M NS1643. Membrane currents of HEK-293 cells heterologously expressing rerg1a (Aa) or rerg1a/1b (Ba) channels were elicited by variable 4-s depolarizing test pulses to potentials between Ϫ100 and ϩ40 mV with 20-mV increments, followed by hyperpolarizations to Ϫ110 mV (rerg1a) or Ϫ100 mV (rerg1a/1b). The holding potential was Ϫ80 mV (see pulse protocols). Aa, representative rerg1a current traces recorded from the same cell before and after application of 10 M NS1643. Ab, current-voltage relationship of rerg1a outward current amplitudes, measured at the end of the depolarizing test pulses. Current amplitudes before and after NS1643 application were normalized to the maximum control current and averaged (n ϭ 6). Ac, peak tail-current amplitudes plotted against the potential of the preceding test pulse. Data points were normalized to the maximum tail-current amplitudes, averaged and fitted with a Boltzmann function, yielding the activation curves with the potentials of half-maximal activation, V 0.5 (control, V 0.5 ϭ Ϫ17.5 mV; NS1643, V 0.5 ϭ Ϫ45.4 mV; n ϭ 6). Ba, rerg1a/1b current traces before and after application of 10 M NS1643. Analyses of outward currents (Bb) and peak tail currents (Bc) (control, V 0.5 ϭ Ϫ17.8 mV; NS1643, V 0.5 ϭ Ϫ55.1 mV; n ϭ 5) were performed as described in Ab and Ac. Data points are means Ϯ S.E.M.
TABLE 2
Effects of 10 M NS1643 on the time course of recovery from inactivation and of deactivation of rerg1a and rerg1a/1b channels heterologously expressed in HEKϪ293 cells Data obtained from experiments as shown in Fig. 6 are given as means Ϯ S.E.M. Tail currents were fitted with the sum of three exponential equations yielding the time constant of recovery from inactivation ( recovery ), the time constants of fast and slow deactivation ( deact,fast and deact,slow ), and the relative contribution of the slowly deactivating current component (S/ (S ϩ F) ). rerg1a at Ϫ110 mV (n ϭ 5) rerg1a/1b at Ϫ100 mV (n ϭ 5) 
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Impact of the Expression System and Presence of Beta Subunits on the NS1643 Effect. herg1a and rerg1a channels were heterologously expressed in X. laevis oocytes, and some comparative measurements were performed using 30 M NS1643. Representative current traces and data analyses, displayed in Fig. 9 , illustrate a moderate activating Fig. 7 . Effect of NS1643 on the voltage dependence and time course of activation of herg1a channels. Human erg1a currents were recorded from stably transfected CHO cells under control conditions or with 10 M NS1643 in the bath for at least 15 min. Experiments from different cells recorded with or without NS1643 were matched for similar herg current amplitudes. Aa and Ab, erg currents were elicited by variable 4-s depolarizing test pulses to potentials between Ϫ100 and ϩ40 mV with 10-mV increments, followed by repolarization to the holding potential of Ϫ100 mV. B, peak tail-current amplitudes plotted against the potential of the preceding test pulse. Data points were normalized to the maximum tail-current amplitudes, averaged, and fitted with a Boltzmann function, yielding the activation curves with the potentials of half-maximal activation, V 0.5 (control, V 0.5 ϭ Ϫ28.4 mV, n ϭ 9; NS1643, V 0.5 ϭ Ϫ55.5 mV, n ϭ 8). C, herg1a currents evoked by an envelope-of-tail protocol without (Ca) or with (Cb) NS1643 in the bath. From a holding potential of Ϫ100 mV, depolarizing pulses to 0, 10, or 20 mV of increasing duration (between 10 and 2824 ms) were applied followed by repolarization to Ϫ100 mV (see pulse protocol). D, time constants (means Ϯ S.E.M.) of herg1a channel activation as function of the membrane potential. Data are derived from experiments without (n ϭ 9) or with NS1643 (n ϭ 7) as shown in C. In the presence of 10 M NS1643, activation was significantly decreased ‫,ءءء(‬ p Ͻ 0.001 for all three potentials). Fig. 8 . Effect of NS1643 on the fully activated current-voltage relationship of herg1a channels. Human erg1a currents were recorded from stably transfected CHO cells either under control conditions or with 10 M NS1643 in the bath for at least 15 min. Experiments from different cells recorded without (Aa) or with (Ab) NS1643 were matched for similar herg current amplitudes. The pulse protocol consisted of 0.5-s depolarizations to ϩ80 mV to fully activate the erg channels, followed by variable 1-s test pulses from ϩ80 to Ϫ120 mV with 10 mV decrements. B, peak current amplitudes are plotted against the test pulse potential to yield the fully activated current-voltage relationship. Data are means Ϯ S.E.M. (n ϭ 7 for control and n ϭ 6 for NS1643). Before averaging, data were normalized to the maximum tail-current amplitude elicited with the test pulse to Ϫ120 mV. C, normalized conductance values derived from the mean current values given in B were fitted with a Boltzmann function (control, V 0.5 ϭ Ϫ65.4 mV, k ϭ Ϫ24.5 mV; NS1643, V 0.5 ϭ Ϫ64.9 mV; k ϭ Ϫ22.9 mV). Conductance was calculated using a reversal potential of Ϫ80.4 mV for both control and NS1643. effect of NS1643 on erg1 channels expressed in X. laevis oocytes as described previously (Casis et al., 2006; Hansen et al., 2006) . The increase of maximum outward current was 34.1 Ϯ 9.4% for rerg1a (n ϭ 3; p ϭ 0.068) and 28.0 Ϯ 14.4% for herg1a (n ϭ 3; p ϭ 0.191). Even with long application periods, a significant shift in the voltage dependence of activation was observed for neither rerg1a nor herg1a channels [rerg, V 0.5; control ϭ Ϫ30.5 Ϯ 1.2 mV; V 0.5; NS1643 ϭ Ϫ33.2 Ϯ 2.6 mV (n ϭ 3; p ϭ 0.337); herg, V 0.5; control ϭ Ϫ28.5 Ϯ 2.7 mV; V 0.5; NS1643 ϭ Ϫ33.7 Ϯ 1.0 mV (n ϭ 3; p ϭ 0.136)]. The inward tail-current amplitudes of rerg1a and herg1a channels determined after a test pulse potential of Ϫ20 mV were augmented by 15.3 Ϯ 4.5% (rerg1a; n ϭ 3; p ϭ 0.057) and 25.1 Ϯ 5.6% (herg1a; n ϭ 3; p ϭ 0.019) after application of 30 M NS1643 (see Fig. 9 ). These data confirmed that the effects of NS1643 on erg1a channels do not differ between human and rat isoforms and that the effects of NS1643 are much less intense on erg1 channels measured in oocytes compared with erg1 channels in a mammalian expression system. X. laevis oocytes endogenously express members of the membrane-spanning KCNE family, which might influence the pharmacological properties of erg channels (Cui et al., 2001; Witchel et al., 2002; Anantharam et al., 2003) . We coexpressed KCNE1 and KCNE2 together with rerg1a and rerg1b in HEK-293 cells to investigate whether these ␤-subunits would be able to attenuate the strong leftward shift in the voltage dependence of activation induced by NS1643. Rat erg1a and erg1b current measurements were performed without and with coexpression of KCNE1 and KCNE2 and in the absence or prolonged presence of 1 or 10 M NS1643 (Fig. 10) . The results of these experiments are summarized in Table 3 . Even in the prolonged presence of NS1643, the effects on the voltage dependence of activation were more pronounced for erg1b than for erg1a. With 1 M NS1643, V 0.5 values differed from control values by approximately 10 mV for erg1a and by approximately 25 mV for erg1b. With 10 M NS1643, these differences amounted to approximately 30 mV for erg1a and approximately 40 mV for erg1b.
Cotransfection with the ␤-subunits had no apparent effect on the macroscopic currents and did not significantly change the voltage dependence of activation of erg1a or erg1b channels. In addition, the effectiveness of NS1643 on erg1a or erg1b channels was similar upon coexpression of the KCNE ␤-subunits. With 1 M NS1643 in the bath, all V 0.5 values were significantly shifted to more negative potentials compared with the V 0.5 control values. Using a concentration of 10 M NS1643, the voltage dependence of activation was shifted yet further to negative potentials. In contrast to the lack of an apparent effect on erg currents, KCNE1 cotransfection with KCNQ1 resulted in pronounced increases in current amplitude and slowing of KCNQ1 current activation demonstrating effective expression of the beta subunit (data not shown). Fig. 9 . Effect of NS1643 on rerg1a and herg1a channels expressed in X. laevis oocytes. A, representative current traces measured in X. laevis oocytes heterologously expressing rerg1a (Aa) and herg1a (Ab) channels elicited by the indicated pulse protocol before (black) and after (gray) application of 30 M NS1643. Ba, mean rerg1a (n ϭ 3) and herg1a (n ϭ 3) current amplitudes after application of 30 M NS1643 normalized to the respective control. Maximum outward currents were determined by an activation protocol consisting of variable 4-s test pulses between Ϫ90 and ϩ60 mV, followed by a hyperpolarization to Ϫ110 mV. Peak tail-current amplitudes were determined by hyperpolarizations to Ϫ110 mV after test pulses to Ϫ20 mV. Bb, mean shift in the potential of half-maximal activation (V 0.5 ) of rerg1a and herg1a channels by 30 M NS1643. V 0.5 values were determined by fitting Boltzmann functions to the tail-current amplitudes obtained with the activation protocol explained in Ba. Data are means Ϯ S.E.M. Fig. 10 . Coexpression of KCNE beta subunits with erg1a and erg1b. Membrane currents of HEK-293 cells expressing different combinations of rat erg1a or erg1b and rat KCNE1 or KCNE2. erg currents were elicited from a holding potential of Ϫ80 mV by variable 4-s depolarizing test pulses up to ϩ40 mV with 10 mV increments, followed by a hyperpolarization to Ϫ100 mV. Families of membrane currents evoked in the absence (A) or presence (B) of 10 M NS1643 were recorded from different cells. Data analysis is given in Table 3 .
Discussion
We recently described that NS1643 exerts remarkable activating effects on rat erg1b channels expressed in HEK-293 cells (Mewe et al., 2008) . We have now investigated the NS1643-induced changes in the biophysical properties of erg1b channels in more detail, and we performed comparative experiments on rat and human erg1a channels demonstrating that the small species differences (Bauer et al., 1998) cannot account for reported differences between herg1a data obtained in oocytes and rerg1b data obtained in HEK-293 cells. Using mainly HEK-293 cells as mammalian expression system, we found that rat erg1b current amplitudes increased in a dose-dependent manner up to 4-fold at a concentration of 10 M NS1643. The most obvious changes in the biophysical properties suited to contribute to the massive current increase were the pronounced leftward shift in the voltage dependence of activation and the marked slowing of deactivation. Although a little less pronounced, both effects of NS1643 could also be elicited on erg1a channels when expressed in HEK or CHO cells. We were surprised to find that erg1b and erg1a channel inactivation in these mammalian cell lines was not altered by incubation with 10 M NS1643.
NS1643 Effects in Different Expression
Systems. The present data confirm and extend our previous results (Mewe et al., 2008 ) that NS1643 induces a dose-dependent dramatic shift in the voltage dependence of activation of rerg1b channels to more negative potentials. We now show that this pronounced leftward shift is also an important mechanism of channel activation by NS1643 of homomeric erg1a and heteromeric erg1a/1b channels when expressed in mammalian cells. The additional experiments performed in X. laevis oocytes confirmed that NS1643 affects erg1 channels much less intense in the oocyte system than in mammalian cells. These results obtained with 30 M NS1643 are in good accordance with previously published data, which show variable effects on the voltage dependence of herg1a activation in oocytes, ranging from no significant shift (Casis et al., 2006; Hansen et al., 2006) up to a leftward shift by approximately 9 mV (Larsen et al., 2010) . In addition, in oocytes, a negative shift in V 0.5 of herg1a activation seems to be concentrationdependent, and it is therefore more apparent with the higher NS1643 concentration of 60 M (Xu et al., 2008) .
For a huge number of erg blocking substances, erg channels expressed in oocytes are known to exhibit a lower drug sensitivity than erg channels expressed in mammalian cells. This lower sensitivity is readily explained by the size of the oocytes and the presence of yolk particles (Witchel et al., 2002; Polak et al., 2009 ). Nevertheless, other mechanisms might contribute to the observed differences in the potency of NS1643 to shift erg1 channel activation. X. laevis oocytes endogenously express members of the KCNE family that have been shown to influence some of the biophysical and pharmacological properties of erg channels (Cui et al., 2001; Anantharam et al., 2003; Bett and Rasmusson, 2008) . We therefore tested whether coexpressed KCNE subunits attenuate the NS1643-induced leftward shift of erg1 channel activation in HEK-293 cells. In these experiments, coexpression of the ␤-subunits KCNE1 and KCNE2 had no effect on the sensitivity of erg1a and erg1b channels to NS1643, suggesting that endogenous KCNE subunits do not significantly contribute to the lower potency of NS1643 in X. laevis oocytes. Significant effects of NS1643 on erg1b gating kinetics concerned the recovery from inactivation and the deactivation process. Because the slowing of deactivation was clearly more pronounced than the slowing of the recovery process, these changes should contribute to the NS1643-induced increase in erg tail-current amplitude. A significant increase in the time constants for recovery from inactivation and for deactivation was also found for erg1a and erg1a/1b channels, expressed in HEK-293 cells. In X. laevis oocytes, varying effects of NS1643 on erg1a channel deactivation have been observed, including no significant effect (Hansen et al., 2006) , moderate slowing (Casis et al., 2006; Larsen et al., 2010) , and more pronounced slowing of deactivation (Xu et al., 2008) .
The fully activated current-voltage relationship was used to estimate the effect of NS1643 on erg1b steady-state inactivation. Despite the fact that the calculated conductance values followed a sigmoidal voltage dependence only at potentials with no or marginal current deactivation, neither the results of the Boltzmann fits nor the fully activated currentvoltage plots pointed to a rightward shift in the erg1b steadystate inactivation curve by NS1643. This interpretation is supported by the surprising finding that the corresponding conductance-voltage relationship determined for herg1a channels was clearly unaffected by 10 M NS1643. Thus, our present results on erg1a and erg1b channels clearly differ Fig. 10 are given as means Ϯ S.E.M. Significance of differences in V 0.5 is given for 1 M versus control and for 10 M versus 1 M NS1643.
from the findings on erg1a channels expressed in oocytes, where a shift in the voltage dependence of inactivation to more positive potentials (Casis et al., 2006; Hansen et al., 2006) and a reduced rate of inactivation (Xu et al., 2008) were described as main mechanisms of activation. Higher Sensitivity to NS1643 of erg1b Compared with erg1a Channels. The activating effects of NS1643 were considerably stronger on erg1a channels expressed in HEK or CHO cells than those exerted in the oocyte system. Nevertheless, most NS1643-induced changes in the biophysical properties of erg1a channels were not as pronounced as for erg1b channels. This applies to the magnitude of the leftward shift in the activation curves, to the increase in steady-state and tail-current amplitudes, as well as to the slowing of channel deactivation. The only exception was the time course of activation, where erg1a exhibited a marked increase in the rate of activation when measured in the presence of 10 M NS1643. In contrast, application of NS1643 did not significantly change the rate of erg1b channel activation. In oocyte experiments on herg1a, accelerated activation has been described mostly in combination with the presence of a NS1643-induced leftward shift of the activation curve (Xu et al., 2008; Larsen et al., 2010) .
We also investigated the effects of NS1643 on erg1a/1b channels, because erg1a and erg1b subunits are often coexpressed and tend to form heteromeric channels (Lees-Miller et al., 1997; London et al., 1997; Jones et al., 2004; Kirchberger et al., 2006) . Rat erg1a/1b channels exhibited a robust NS1643-induced increase in current amplitude, which was in between the results obtained for the corresponding homomeric channels. With almost Ϫ40 mV, the shift in the activation curve was similarly strong as for erg1b. Taken together, the present results show that the erg1b isoform is more sensitive to NS1643 than erg1a channels. This is in accordance with the recent finding that also herg1b channels expressed in oocytes are more sensitive than herg1a to NS1643 (Larsen et al., 2010) .
Mechanism of Action of NS1643. The present experiments with NS1643 and erg1b channels revealed differences in the time course and in the use dependence of the increase in current amplitude and the shift in the voltage dependence of activation, indicating the existence of more than one mechanism of channel activation. Use dependence of herg current inhibition is a common feature of several erg blockers, which preferentially block open channels, and many of them require channel inactivation for high-affinity binding (for review, see Li and Dong, 2010) . Nevertheless, in our experiments with NS1643, almost maximal increase in current amplitude was evident with the first pulse sequence after a prolonged period at a negative holding potential, suggesting efficient binding of NS1643 to erg1b channels in the closed state, as has been recently shown for 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574) (Gerlach et al., 2010) .
Similar to findings in herg1a channels in oocytes (Casis et al., 2006) , a very high concentration of NS1643 led to a less intense increment in erg1b currents with a more pronounced attenuation of the agonist activity at more positive potentials. This effect, which occurred at 100 M in oocytes and at 30 M in the present study, was interpreted as an additional erg channel blocking property of NS1643 (Casis et al., 2006) . Phe656 of herg1a, a residue that interacts with most classic herg blockers, was suggested as a possible low-affinity binding site. Thus, different binding sites for NS1643 seem to exist in erg1a channels, suggesting that NS1643 possibly acts from both the external (Xu et al., 2008; Grunnet et al., 2011) and internal sides of the membrane. The presence of different binding sites would also well explain the differences in the time course and use dependence of the increase in current amplitude and the shift in the voltage dependence of activation found for erg1b channels in the present study.
Our experiments did not identify which additional mechanism-apart from the leftward shift in activation and slowing of deactivation-is involved in the observed increase in erg1b current amplitude, because erg1b channel inactivation was not affected by NS1643. Other possible mechanisms that could contribute to the drug-induced increase in erg wholecell current are an enhanced maximal channel open probability or a reduced erg channel affinity to external Na ϩ , thus reducing the Na ϩ block suggested to underlie the paradoxical agonist effect of external K ϩ on herg current amplitude (Numaguchi et al., 2000; Mullins et al., 2002) .
The slow time course of the NS1643-induced leftward shift in the activation curves of erg1a and erg1b channels combined with its use dependence could underlie the fact that it has not been observed or described in other studies also using mammalian cells as expression system or in experiments on native erg1 channels of cardiac myocytes. Future experiments with prolonged exposure to NS1643 could clarify this issue and would perhaps help to understand the in vivo effects of the drug.
